首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

2055118

人造器官市場（按器官類型分類）

Artificial Organ Market, By Organ Type (Artificial Heart, Artificial Kidney, Artificial Liver, By Patient Type, By End User, By Application, By Technology, By Geography )

出版日期: 2026年03月11日 | 出版商:

Coherent Market Insights | 英文 168 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，人造器官市場規模將達到234億美元，到2033年將達到422.3億美元。預計從2026年到2033年，其複合年成長率將達到8.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	234億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	8.80%	2033年市場規模預測：	422.3億美元

全球人工器官市場是醫療技術領域的創新前沿，它不僅解決了全球捐贈器官嚴重短缺的問題，也為數百萬個器官衰竭患者帶來了希望。人工器官旨在取代或輔助功能受損的生物器官，涵蓋了機械裝置、生物工程組織和混合系統等多種技術。

這個市場涵蓋多種器官類型，包括人工心臟、腎臟、肺臟、肝臟、胰臟和四肢，每一種都運用了先進的材料科學、生物相容性工程和尖端製造技術。慢性病日益普遍、人口老化以及文明病導致的器官衰竭病例不斷增加，都在推動人工器官解決方案的需求。這些拯救生命的技術涵蓋範圍廣泛，從維持等待移植患者生命的臨時過渡裝置，到恢復正常生理功能的永久性器官替代裝置。

該市場充分利用生物材料、3D列印、組織工程和再生醫學領域的尖端創新技術，涵蓋植入式設備和外部支援系統。隨著全球醫療系統面臨器官捐贈者短缺和漫長等待名單的困境，人工器官正成為一種極具前景的替代方案，它具有即時可用、可客製化規格以及消除傳統器官移植相關免疫排斥風險等優點。

市場動態

全球人工器官市場受多種強勁因素驅動，凸顯其在現代醫學中的關鍵作用。首要促進因素是全球捐贈器官的嚴重短缺。目前，美國有超過10萬人正在等待器官移植，全球也存在類似情況，這使得人工器官替代方案的需求變得迫切。糖尿病、心血管疾病、腎衰竭和肝硬化等慢性疾病的日益普遍，以及人口老化，進一步推動了對器官替代解決方案的需求。

生物材料、3D生物列印、組織工程和奈米技術的進步正在革新人工器官的研發，顯著提升了人工器官的生物相容性、耐久性和功能性。政府對研發的支持、不斷上漲的醫療成本以及人們對人工器官益處的日益關注，都進一步加速了市場成長。然而，該市場也面臨許多限制因素，例如極高的研發和製造成本，使得人工器官價格昂貴，許多患者難以負擔。嚴格的監管核准流程，需要進行大量的臨床試驗和安全檢驗，導致研發週期漫長，並給製造商帶來了巨大的財務壓力。生物相容性、設備耐久性、感染風險以及如何實現與天然器官相當的功能等技術挑戰，仍然是主要的障礙。此外，保險公司報銷額度有限以及人工器官引進過程中所存在的倫理問題，也限制市場的擴張。

儘管面臨諸多挑戰，新興市場憑藉著不斷完善的醫療基礎設施、日益興盛的醫療旅遊業和不斷成長的可支配收入，蘊藏著巨大的機會。學術機構、生物技術公司和醫療設備製造商之間的合作正在促進創新並加速產品研發。將人工智慧、機器學習和物聯網技術融入人工器官的設計，為開發能夠即時監測和調整自身功能的智慧、自適應設備提供了突破性的契機，並有望徹底改變患者的治療效果和市場動態。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數對全球人造器官市場的主要參與者進行了分析：公司亮點、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球人造器官市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過用於分析全球人造器官市場的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Asahi Kasei Corporation
Fresenius Medical Care AG
Baxter International Inc.
SynCardia Systems LLC
Jarvik Heart Inc.
Cochlear Limited
Ottobock SE & Co. KGaA
Second Sight Medical Products
Ekso Bionics Holdings Inc.
Abiomed Inc.
Organovo Holdings Inc.
Carmat SA

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8264

Artificial Organ Market is estimated to be valued at USD 23.40 Bn in 2026 and is expected to reach USD 42.23 Bn by 2033, growing at a compound annual growth rate (CAGR) of 8.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 23.40 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	8.80%	2033 Value Projection:	USD 42.23 Bn

The global artificial organ market represents a revolutionary frontier in medical technology, addressing the critical shortage of donor organs worldwide while offering hope to millions of patients suffering from organ failure. Artificial organs, engineered medical devices designed to replace or support the function of failing biological organs, encompass a diverse range of technologies including mechanical devices, bioengineered tissues, and hybrid systems.

This market spans various organ types such as artificial hearts, kidneys, lungs, liver, pancreas, and limbs, each utilizing sophisticated materials science, biocompatibility engineering, and advanced manufacturing techniques. The increasing prevalence of chronic diseases, aging populations, and lifestyle-related organ failures has intensified the demand for artificial organ solutions. These life-saving technologies range from temporary bridging devices that sustain patients awaiting transplants to permanent organ replacements that restore normal physiological function.

The market encompasses both implantable devices and external support systems, leveraging cutting-edge innovations in biomaterials, 3D printing, tissue engineering, and regenerative medicine. As healthcare systems worldwide grapple with organ donor shortages and extended waiting lists, artificial organs emerge as a promising alternative, offering immediate availability, customizable specifications, and elimination of immunological rejection risks associated with traditional organ transplantation.

Market Dynamics

The global artificial organ market is propelled by several compelling drivers that underscore its critical importance in modern healthcare. The primary driver stems from the severe shortage of donor organs worldwide, with over 100,000 Americans currently on organ waiting lists and similar statistics globally, creating an urgent need for artificial alternatives. Rising prevalence of chronic diseases such as diabetes, cardiovascular disorders, kidney failure, and liver cirrhosis, coupled with aging populations, significantly amplifies demand for organ replacement solutions.

Technological advancements in biomaterials, 3D bioprinting, tissue engineering, and nanotechnology are revolutionizing artificial organ development, making devices more biocompatible, durable, and functionally superior. Government initiatives supporting research and development, increased healthcare expenditure, and growing awareness about artificial organ benefits further accelerate market growth. However, the market faces substantial restraints including extremely high development and manufacturing costs, making artificial organs expensive and potentially inaccessible to many patients. Stringent regulatory approval processes requiring extensive clinical trials and safety validations create lengthy timelines and significant financial barriers for manufacturers. Technical challenges related to biocompatibility, device longevity, infection risks, and achieving natural organ functionality remain significant hurdles. Limited reimbursement coverage by insurance providers and ethical concerns regarding artificial organ implementation also constrain market expansion.

Despite these challenges, immense opportunities exist through emerging markets with improving healthcare infrastructure, increasing medical tourism, and rising disposable incomes. Collaborative research between academic institutions, biotechnology companies, and medical device manufacturers is fostering innovation and accelerating product development. The integration of artificial intelligence, machine learning, and IoT technologies in artificial organ design presents revolutionary opportunities for smart, adaptive devices that can monitor and adjust their functionality in real-time, potentially transforming patient outcomes and market dynamics.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global artificial organ market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study include leading Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Asahi Kasei Corporation, Fresenius Medical Care AG, Baxter International Inc., SynCardia Systems LLC, Jarvik Heart Inc., Cochlear Limited, Ottobock SE & Co. KGaA, Second Sight Medical Products, Ekso Bionics Holdings Inc., Abiomed Inc., Organovo Holdings Inc., and Carmat SA.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
The global artificial organ market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global artificial organ market.

Market Segmentation

Organ Type Insights (Revenue, USD Bn, 2021 - 2033)
Artificial Heart
- Ventricular Assist Devices (VADs)
- Total Artificial Hearts (TAHs)
Artificial Kidney
- Wearable Artificial Kidneys
- Implantable Renal Devices
Artificial Liver
- Bioartificial Liver Support Systems
- Extracorporeal Liver Assist Devices
Artificial Pancreas
- Closed-Loop Insulin Delivery Systems
- Implantable Glucose Monitors
Artificial Lungs
- Extracorporeal Membrane Oxygenation (ECMO)
- Implantable Oxygenators
Sensory Organs
- Cochlear Implants (Hearing)
- Retinal Implants (Vision)
Corneal Implants
- Bionic Limbs
- Myoelectric Prosthetics
Others (Neuro-Controlled Prostheses)
Patient Type Insights (Revenue, USD Bn, 2021 - 2033)
Neonates
Pediatric
Adult
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Transplant Centers
Ambulatory Surgical Centers
Emergency and Trauma Centers
Home Care Settings
Others (Research Institutes, etc.)
Application Insights (Revenue, USD Bn, 2021 - 2033)
Transplantation
Chronic Disease Management
Other Emergency or Acute Care
Technology Insights (Revenue, USD Bn, 2021 - 2033)
Mechanical
Electronic or Bionic
Biomechanical Hybrid
Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Abbott Laboratories
Medtronic plc
Boston Scientific Corporation
Asahi Kasei Corporation
Fresenius Medical Care AG
Baxter International Inc.
SynCardia Systems LLC
Jarvik Heart Inc.
Cochlear Limited
Ottobock SE & Co. KGaA
Second Sight Medical Products
Ekso Bionics Holdings Inc.
Abiomed Inc.
Organovo Holdings Inc.
Carmat SA

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Artificial Organ Market, By Organ Type
- Global Artificial Organ Market, By Patient Type
- Global Artificial Organ Market, By End User
- Global Artificial Organ Market, By Application
- Global Artificial Organ Market, By Technology
- Global Artificial Organ Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Artificial Organ Market, By Organ Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Artificial Heart
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Ventricular Assist Devices (VADs)
  - Total Artificial Hearts (TAHs)
Artificial Kidney
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Wearable Artificial Kidneys
  - Implantable Renal Devices
Artificial Liver
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Bioartificial Liver Support Systems
  - Extracorporeal Liver Assist Devices
Artificial Pancreas
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Closed-Loop Insulin Delivery Systems
  - Implantable Glucose Monitors
Artificial Lungs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Extracorporeal Membrane Oxygenation (ECMO)
  - Implantable Oxygenators
Sensory Organs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Cochlear Implants (Hearing)
  - Retinal Implants (Vision)
Corneal Implants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
  - Bionic Limbs
  - Myoelectric Prosthetics
Others (Neuro-Controlled Prostheses)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Artificial Organ Market, By Patient Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Neonates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Artificial Organ Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Transplant Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Emergency and Trauma Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Home Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (Research Institutes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Artificial Organ Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Chronic Disease Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Emergency or Acute Care
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Artificial Organ Market, By Technology, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Mechanical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Electronic or Bionic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Biomechanical Hybrid
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Biomaterials-Based Technology (e.g., Decellularized Scaffolds, 3D-Bioprinted Tissues)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Artificial Organ Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Organ Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Patient Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Medtronic plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Asahi Kasei Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Fresenius Medical Care AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Baxter International Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
SynCardia Systems LLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Jarvik Heart Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Cochlear Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ottobock SE & Co. KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Second Sight Medical Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Ekso Bionics Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abiomed Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Organovo Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Carmat SA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies